Pfizer Receives European Approval for Oncology Biosimilar, TRAZIMERA™ (trastuzumab)
Go back to Pfizer Receives European Approval for Oncology Biosimilar, TRAZIMERA™ (trastuzumab)| Pfizer Inc. (NYSE: PFE) | Delayed: 28.93 +0.38 (1.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.55 | 52 Week High | $37.39 | |||
| Open | $28.79 | 52 Week Low | $28.25 | |||
| Day High | $29.09 | P/E | 17.53 | |||
| Day Low | $28.71 | EPS | $1.65 | |||
| Volume | 22,059,031 | |||||
